Geller Advisors LLC Abb Vie Inc. Transaction History

Geller Advisors LLC

$1.44 Billion
Q3 2024

A detailed history of Geller Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Geller Advisors LLC holds 10,081 shares of ABBV stock, worth $1.81 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

10,081

Previous 9,309 8.29%

Holding current value

$1.81 Million

Previous $1.6 Million 24.69%

% of portfolio

0.14%

Previous 0.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$163.84 - $199.33 $126,484 - $153,882	772 Added 8.29%	10,081 $1.99 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $315,616 - $368,569	2,039 Added 28.05%	9,309 $1.6 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $39,315 - $44,796	246 Added 3.5%	7,270 $1.32 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $177,641 - $200,066	-1,291 Reduced 15.53%	7,024 $1.09 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $247,275 - $286,257	1,851 Added 28.64%	8,315 $1.24 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $218,641 - $272,085	1,650 Added 34.28%	6,464 $870,000
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $189,149 - $217,834	-1,308 Reduced 21.37%	4,814 $767,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $463,476 - $555,830	-3,351 Reduced 35.37%	6,122 $989,000
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $91,531 - $104,980	682 Added 7.76%	9,473 $1.27 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $8,394 - $10,672	61 Added 0.7%	8,791 $1.35 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $25,604 - $31,767	194 Added 2.27%	8,730 $1.42 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $107 - $135	1 Added 0.01%	8,536 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $401,234 - $455,461	3,771 Added 79.16%	8,535 $921,000
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $526 - $586	-5 Reduced 0.1%	4,764 $537,000
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $89,717 - $98,767	-877 Reduced 15.53%	4,769 $516,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $5,755 - $6,755	67 Added 1.2%	5,646 $495,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $145,199 - $194,298	1,979 Added 54.97%	5,579 $548,000
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $2,193 - $3,324	34 Added 0.95%	3,600 $274,000
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $42,556 - $53,247	-590 Reduced 14.2%	3,566 $316,000
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $261,744 - $314,692	4,156 New	4,156 $315,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $177,422 - $208,817	-2,300 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $160,655 - $205,206	2,300	2,300 $204,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geller Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geller Advisors LLC with notifications on news.

Account

Geller Advisors LLC Abb Vie Inc. Transaction History